Cargando…
Clinical guideline SEOM: hepatocellular carcinoma
Hepatocellular carcinoma (HCC) represents the second leading cause of cancer-related death worldwide. Surveillance with abdominal ultrasound every 6 months should be offered to patients with a high risk of developing HCC: Child-Pugh A–B cirrhotic patients, all cirrhotic patients on the waiting list...
Autores principales: | Sastre, J., Díaz-Beveridge, R., García-Foncillas, J., Guardeño, R., López, C., Pazo, R., Rodriguez-Salas, N., Salgado, M., Salud, A., Feliu, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689753/ https://www.ncbi.nlm.nih.gov/pubmed/26607931 http://dx.doi.org/10.1007/s12094-015-1451-3 |
Ejemplares similares
-
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
por: Gómez-España, Mª A., et al.
Publicado: (2021) -
SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
por: Martin-Richard, M., et al.
Publicado: (2016) -
SEOM clinical guideline on unknown primary cancer (2017)
por: Losa, F., et al.
Publicado: (2017) -
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
por: Vera, R., et al.
Publicado: (2016) -
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
por: Gómez-España, M. A., et al.
Publicado: (2018)